Growth Metrics

Pacific Biosciences Of California (PACB) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 6.28%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 9.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 22.80%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 29.36%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -27.72%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -0.27%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 77.20%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -20.37%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 19.32%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 21.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 21.43%
Dec 31, 2025 32.73%
Sep 30, 2025 34.82%
Jun 30, 2025 22.62%
Mar 31, 2025 18.08%
Dec 31, 2024 2.25%
Jun 30, 2024 -47.75%
Mar 31, 2024 -50.15%
Dec 31, 2023 -60.80%
Sep 30, 2023 -53.24%
Jun 30, 2023 -22.22%
Mar 31, 2023 -49.00%
Dec 31, 2022 -52.88%
Sep 30, 2022 -54.91%
Jun 30, 2022 -52.61%
Mar 31, 2022 -45.99%
Dec 31, 2021 -21.97%
Jun 30, 2021 -2.92%
Mar 31, 2021 -7.13%
Dec 31, 2020 12.32%
Sep 30, 2020 4.55%
Jun 30, 2020 -14.04%
Mar 31, 2020 80.60%
Dec 31, 2019 -5.61%
Sep 30, 2019 0.16%
Jun 30, 2019 5.72%
Mar 31, 2019 -8.63%
Dec 31, 2018 -128.70%
Sep 30, 2018 4.20%
Jun 30, 2018 -23.34%
Mar 31, 2018 8.10%
Dec 31, 2017 -10.32%
Sep 30, 2017 -48.63%
Jun 30, 2017 -4.90%
Mar 31, 2017 -4.94%
Dec 31, 2016 -1.95%
Sep 30, 2016 -43.95%
Jun 30, 2016 -9.12%
Mar 31, 2016 -5.06%
Dec 31, 2015 55.98%
Sep 30, 2015 3.63%
Jun 30, 2015 29.51%
Mar 31, 2015 -11.83%
Dec 31, 2014 0.78%
Sep 30, 2014 37.33%
Jun 30, 2014 26.16%
Mar 31, 2014 21.77%
Dec 31, 2013 28.57%
Sep 30, 2013 36.40%